CLIP1 and pancreatic neoplasm: Our study shows that CLIP-170 can be acetylated in cells; however, the level of CLIP-170 acetylation is not affected by the HDAC6 inhibitor tubacin, although the deacetylase activity is necessary for the role of HDAC6 in regulating pancreatic cancer cell motility.